查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1751229

性病診斷市場規模、佔有率、趨勢分析報告：按應用、產品、技術、檢測地點、地區、細分市場預測，2025-2030 年

STD Diagnostics Market Size, Share & Trends Analysis Report By Application (HIV Testing, HSV Testing, Chlamydia Testing), By Product, By Technology, By Location Of Testing, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 156 Pages | 商品交期: 2-10個工作天內

價格

性病診斷市場的成長與趨勢：

根據Grand View Research, Inc.的最新報告，全球性病診斷市場規模預計到2030年將達到160.8億美元，2025年至2030年期間的複合年成長率為7.1%。

性行為感染傳染病（STD）負擔日益加重，以及各國政府和非營利組織努力提高年輕一代的認知並鼓勵定期篩檢，是推動市場成長的主要因素。根據世界衛生組織的數據，全球每年報告約3.74億例梅毒、淋病、披衣菌感染和滴蟲病等性傳染病新發病例。

新一代HIV檢測套組和多重PCR產品等先進產品的開發和商業化，使醫生能夠及時診斷和區分各種性傳染感染，並提供適當的治療。總部位於韓國的診斷公司Seegene, Inc.提供Allplex、Anyplex和Seeplex等廣泛的產品組合，可檢測各種病原體。例如，Allplex STI/BV Panel Assay可在一次檢測中區分出28種病原體。 2022年4月，Seegene, Inc.宣布開發Allplex HPV HR檢測。

Allplex HPV HR 檢測是全球首個商業化的「3 Ct」 PCR 檢測。 Seegene 致力於將這項技術應用於其整個產品鏈，包括性傳染感染 (STI)、尿道感染(UTI) 和呼吸道病毒 (RV) 檢測。這項策略性技術進步預計將為公司在性行為感染傳染病 (STD) 診斷行業擴大市場佔有率提供進一步優勢。

《愛滋病毒國家戰略計畫》是美國到2030年消除人類免疫力缺乏病毒流行的藍圖。該計劃從2021年到2025年，是美國第三個五年期愛滋病毒國家計劃，其十年目標是到2030年將人類免疫力缺乏病毒新興感染減少一半至90%。此外，《病毒性肝炎國家戰略計畫》重點關注性傳播的B型肝炎和C肝。 2021年1月，美國衛生與公眾服務部（HHS）發布了一項國家戰略，以應對美國病毒性肝炎帶來的可預防和重大公共衛生威脅。政府的有利行動正在為性病診斷行業的擴張營造良好的氛圍。

各公司都在採取策略性舉措，支持新產品開發和監管核准，並加強其性傳染病 (STD) 診斷產品系列。例如，2020 年 8 月，DiaSorin 公司獲得美國FDA 的 510(k)核准，推出用於診斷乙型肝炎病毒 (HBV) 感染的 LIAISON XL MUREX 抗 HBe 試劑。此免疫測量產品基於化學冷光原理運作。

性病診斷市場報告重點

  • 到 2024 年，耗材領域將佔據市場主導地位，收益佔有率達 70.01%，並且由於檢測率高和多種性病診斷檢測方法的商業化，預計預測期內該領域將以最快的複合年成長率成長。
  • 從技術角度來看，由於高通量PCR技術的使用日益增多，以及NAAT檢測在HIV檢測中的應用日益普及，分子診斷領域預計將在預測期內實現最快的複合年成長率。能夠同時檢測多種病原體的多重PCR檢測技術的發展，預計也將有助於性病診斷產業的成長。
  • 根據應用，預計 2024 年 HIV 檢測領域將在 STD 診斷產業中佔據主導地位。這是由於 HIV 盛行率高、分子檢測產品核可增加以及政府的有利措施等因素造成的。
  • 由於性病檢測率上升、可支配收入增加以及新興國家性病患病率高，預計亞太國家在預測期內將以最快的速度成長。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章 性病診斷市場變數、趨勢與範圍

  • 市場介紹/電網展望
  • 市場規模和成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 性病診斷市場分析工具
    • 波特分析
    • PESTEL分析

第4章 性病診斷市場：產品評估與趨勢分析

  • 細分儀表板
  • 性病診斷市場：2024 年和 2030 年產品差異分析
  • 設備和服務
  • 耗材
  • 軟體

第5章 性病診斷市場：應用估計與趨勢分析

  • 細分儀表板
  • 性病診斷市場：2024 年和 2030 年應用趨勢分析
  • CT/NG檢查
  • 梅毒檢測
    • PCR檢測
    • 非PCR檢測
  • 淋病檢測
  • HSV偵測
    • PCR檢測
    • 非PCR檢測
  • HPV檢測
  • HIV檢測
  • 脲原體和黴漿菌檢測
  • 滴蟲
  • VZV檢測
    • PCR檢測
    • 非PCR檢測

第6章 性病診斷市場：技術評估與趨勢分析

  • 細分儀表板
  • 性病診斷市場：2024 年與 2030 年技術變遷分析
  • 免疫檢測
  • 分子診斷
  • 其他

第7章性行為感染傳染病診斷市場：檢測地點估計與趨勢分析

  • 細分儀表板
  • 性病診斷市場：檢測變異分析（2024 年和 2030 年）
  • 商業/私人實驗室
  • 公共衛生研究所

第8章性行為感染傳染病診斷市場：區域估計與趨勢分析

  • 2024 年及 2030 年各地區性病診斷市場佔有率
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭態勢

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司分類
  • 公司熱圖分析
  • 公司簡介
    • BD
    • F. Hoffmann-La Roche Ltd
    • Hologic Inc.
    • Abbott
    • Cepheid（Danaher）
    • Qiagen
    • OraSure Technologies, Inc.
    • Bio-Rad Laboratories, Inc.
    • bioMerieux SA
    • Thermo Fisher Scientific, Inc.
    • Seegene Inc.
    • DiaSorin SpA
Product Code: 978-1-68038-686-8

STD Diagnostics Market Growth & Trends:

The global STD diagnostics market size is estimated to reach USD 16.08 billion by 2030, expanding at a CAGR of 7.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. The increasing disease burden of Sexually Transmitted Disease (STD) and efforts by government & non-profit organizations to increase awareness and encourage regular screenings among the younger population are the key factors augmenting the market growth. According to WHO data, around 374 million new cases of syphilis, gonorrhea, chlamydia, and trichomoniasis are recorded every year globally.

Development and commercialization of advanced products, such as next-generation HIV testing kits and multiplex PCR products, enable physicians to timely diagnose & distinguish a range of STIs and provide appropriate treatment. Seegene, Inc., a South Korea-based diagnostic company, provides a wide portfolio of Allplex, Anyplex, and Seeplex products that detect various causative agents. For instance, Allplex STI/BV Panel Assay can distinguish 28 causative agents in a single test. In April 2022, Seegene, Inc. announced the development of Allplex HPV HR Detection.

Allplex HPV HR Detection is the world's first commercialized '3 Ct' PCR assay. Seegene is focusing to apply this technology to its entire product chain, including STI, Urinary Tract Infection (UTI), and Respiratory Virus (RV) assays. This strategic technological advancement is expected to provide an additional advantage to the company that can help increase its share in the Sexually Transmitted Disease (STD) diagnostics industry.

The HIV National Strategic Plan is a roadmap for eliminating the human immunodeficiency virus pandemic in the U.S. by 2030. The HIV Plan, which will run from 2021 to 2025, is the country's third five-year national HIV plan in a row, with a 10-year goal of halving new human immunodeficiency virus infections by 90% by 2030. Furthermore, the Viral Hepatitis National Strategic Plan focuses on hepatitis B and C, which are sexually transmitted. In January 2021, the US Department of Health and Human Services (HHS) released a nationwide strategy to address the preventable, substantial public health threats posed by viral hepatitis in the United States. The government's beneficial actions create a favorable atmosphere for the expansion of the STD diagnostics industry.

Companies are engaging in strategic initiatives that aid in the development of new products, and regulatory approvals as well as enhance their STD diagnostics product portfolio. For instance, in August 2020, DiaSorin, Inc. received 510 (k) approval from U.S. FDA for introducing LIAISON XL MUREX anti-HBe. It is used for the diagnosis of HBV infection. This immunoassay product works on the principle of chemiluminescence.

STD Diagnostics Market Report Highlights:

  • The consumables segment dominated the market in 2024 with a revenue share of 70.01% and is anticipated to grow at the fastest CAGR over the forecast period owing to high testing rates for the diagnosis of STDs and the commercialization of several assays
  • Based on technology, the molecular diagnostics segment is estimated to grow at the fastest CAGR during the forecast period owing to the increasing use of high-throughput PCR technology and the recommendation of NAAT tests for HIV testing. The development of multiplex PCR tests for the simultaneous detection of multiple pathogens is also expected to contribute to the STD diagnostics industry's growth
  • Based on application, the HIV testing segment is expected to dominate the STD diagnostics industry in 2024, due to factors such as the high incidence rate of the disease, increasing product approvals for molecular tests, and favorable government initiatives
  • Asia Pacific region is anticipated to experience the fastest growth over the forecast period due to an increase in testing rates for STDS, a rise in disposable income, and high disease prevalence of STD in developing countries

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. STD Diagnostics Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. STD Diagnostics Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. STD Diagnostics Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. STD Diagnostics Market: Product Movement Analysis, 2024 & 2030 (USD Million)
  • 4.3. Instruments and Services
    • 4.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Consumables
    • 4.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Software
    • 4.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. STD Diagnostics Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. STD Diagnostics Market: Application Movement Analysis, 2024 & 2030 (USD Million)
  • 5.3. CT/NG testing
    • 5.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Syphilis testing
    • 5.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.2. PCR testing
      • 5.4.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.3. Non-PCR testing
      • 5.4.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Gonorrhea testing
    • 5.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. HSV testing
    • 5.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.2. PCR testing
      • 5.6.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.3. Non-PCR testing
      • 5.6.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. HPV testing
    • 5.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. HIV testing
    • 5.8.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.9. Ureaplasma & Mycoplasma testing
    • 5.9.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.10. Trichomonas
    • 5.10.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.11. VZV testing
    • 5.11.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.11.2. PCR testing
      • 5.11.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.11.3. Non-PCR testing
      • 5.11.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. STD Diagnostics Market: Technology Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. STD Diagnostics Market: Technology Movement Analysis, 2024 & 2030 (USD Million)
  • 6.3. Immunoassay
    • 6.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Molecular Diagnostics
    • 6.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Other
    • 6.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. STD Diagnostics Market: Location of Testing Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. STD Diagnostics Market: Location of Testing Movement Analysis, 2024 & 2030 (USD Million)
  • 7.3. Commercial/Private labs
    • 7.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Public Health Labs
    • 7.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. STD Diagnostics Market: Regional Estimates & Trend Analysis

  • 8.1. STD Diagnostics Market Share, By Region, 2024 & 2030, USD Million
  • 8.2. North America
    • 8.2.1. North America STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. U.S. STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.3. Canada
      • 8.2.3.1. Canada STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.4. Mexico
      • 8.2.4.1. Mexico STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3. Europe
    • 8.3.1. Europe STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.2. UK
      • 8.3.2.1. UK STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.3. Germany
      • 8.3.3.1. Germany STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.4. France
      • 8.3.4.1. France STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.5. Italy
      • 8.3.5.1. Italy STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.6. Spain
      • 8.3.6.1. Spain STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.7. Denmark
      • 8.3.7.1. Denmark STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.8. Sweden
      • 8.3.8.1. Sweden STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.9. Norway
      • 8.3.9.1. Norway STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2. Japan
      • 8.4.2.1. Japan STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. China
      • 8.4.3.1. China STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. India
      • 8.4.4.1. India STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.5. Australia
      • 8.4.5.1. Australia STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.6. South Korea
      • 8.4.6.1. South Korea STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.7. Thailand
      • 8.4.7.1. Thailand STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Latin America
    • 8.5.1. Latin America STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Brazil STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. Argentina
      • 8.5.3.1. Argentina STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Middle East and Africa
    • 8.6.1. Middle East and Africa STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2. South Africa
      • 8.6.2.1. South Africa STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. Saudi Arabia
      • 8.6.3.1. South Africa STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.4. UAE
      • 8.6.4.1. UAE STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.5. Kuwait
      • 8.6.5.1. Kuwait STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis by Key Market Participants
  • 9.2. Company Categorization
  • 9.3. Company Heat Map Analysis
  • 9.4. Company Profiles
    • 9.4.1. BD
      • 9.4.1.1. Participant's Overview
      • 9.4.1.2. Financial Performance
      • 9.4.1.3. Product Benchmarking
      • 9.4.1.4. Recent Developments/ Strategic Initiatives
    • 9.4.2. F. Hoffmann-La Roche Ltd
      • 9.4.2.1. Participant's Overview
      • 9.4.2.2. Financial Performance
      • 9.4.2.3. Product Benchmarking
      • 9.4.2.4. Recent Developments/ Strategic Initiatives
    • 9.4.3. Hologic Inc.
      • 9.4.3.1. Participant's Overview
      • 9.4.3.2. Financial Performance
      • 9.4.3.3. Product Benchmarking
      • 9.4.3.4. Recent Developments/ Strategic Initiatives
    • 9.4.4. Abbott
      • 9.4.4.1. Participant's Overview
      • 9.4.4.2. Financial Performance
      • 9.4.4.3. Product Benchmarking
      • 9.4.4.4. Recent Developments/ Strategic Initiatives
    • 9.4.5. Cepheid (Danaher)
      • 9.4.5.1. Participant's Overview
      • 9.4.5.2. Financial Performance
      • 9.4.5.3. Product Benchmarking
      • 9.4.5.4. Recent Developments/ Strategic Initiatives
    • 9.4.6. Qiagen
      • 9.4.6.1. Participant's Overview
      • 9.4.6.2. Financial Performance
      • 9.4.6.3. Product Benchmarking
      • 9.4.6.4. Recent Developments/ Strategic Initiatives
    • 9.4.7. OraSure Technologies, Inc.
      • 9.4.7.1. Participant's Overview
      • 9.4.7.2. Financial Performance
      • 9.4.7.3. Product Benchmarking
      • 9.4.7.4. Recent Developments/ Strategic Initiatives
    • 9.4.8. Bio-Rad Laboratories, Inc.
      • 9.4.8.1. Participant's Overview
      • 9.4.8.2. Financial Performance
      • 9.4.8.3. Product Benchmarking
      • 9.4.8.4. Recent Developments/ Strategic Initiatives
    • 9.4.9. bioMerieux SA
      • 9.4.9.1. Participant's Overview
      • 9.4.9.2. Financial Performance
      • 9.4.9.3. Product Benchmarking
      • 9.4.9.4. Recent Developments/ Strategic Initiatives
    • 9.4.10. Thermo Fisher Scientific, Inc.
      • 9.4.10.1. Participant's Overview
      • 9.4.10.2. Financial Performance
      • 9.4.10.3. Product Benchmarking
      • 9.4.10.4. Recent Developments/ Strategic Initiatives
    • 9.4.11. Seegene Inc.
      • 9.4.11.1. Participant's Overview
      • 9.4.11.2. Financial Performance
      • 9.4.11.3. Product Benchmarking
      • 9.4.11.4. Recent Developments/ Strategic Initiatives
    • 9.4.12. DiaSorin S.p.A
      • 9.4.12.1. Participant's Overview
      • 9.4.12.2. Financial Performance
      • 9.4.12.3. Product Benchmarking
      • 9.4.12.4. Recent Developments/ Strategic Initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global STD diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 4 Global STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 5 Global STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 6 Global STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 7 North America STD diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 8 North America STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 9 North America STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 10 North America STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 11 North America STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 12 U.S. STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 13 U.S. STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 14 U.S. STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 15 U.S. STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 16 Canada STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 17 Canada STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 18 Canada STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 19 Canada STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 20 Mexico STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 21 Mexico STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 22 Mexico STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 23 Mexico STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 24 Europe STD diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 25 Europe STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 26 Europe STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 27 Europe STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 28 Europe STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 29 UK STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 30 UK STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 31 UK STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 32 UK STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 33 Germany STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 34 Germany STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 35 Germany STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 36 Germany STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 37 France STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 38 France STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 39 France STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 40 France STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 41 Italy STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 42 Italy STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 43 Italy STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 44 Italy STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 45 Spain STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 46 Spain STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 47 Spain STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 48 Spain STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 49 Denmark STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 50 Denmark STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 51 Denmark STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 52 Denmark STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 53 Sweden STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 54 Sweden STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 55 Sweden STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 56 Sweden STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 57 Norway STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 58 Norway STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 59 Norway STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 60 Norway STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific STD diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 63 Asia Pacific STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 64 Asia Pacific STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 66 Japan STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 67 Japan STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 68 Japan STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 69 Japan STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 70 China STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 71 China STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 72 China STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 73 China STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 74 India STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 75 India STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 76 India STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 77 India STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 78 Australia STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 79 Australia STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 80 Australia STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 81 Australia STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 82 South Korea STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 83 South Korea STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 84 South Korea STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 85 South Korea STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 86 Thailand STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 87 Thailand STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 88 Thailand STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 89 Thailand STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 90 Latin America STD diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 91 Latin America STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 92 Latin America STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 93 Latin America STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 94 Latin America STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 95 Brazil STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 96 Brazil STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 97 Brazil STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 98 Brazil STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 99 Argentina STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 100 Argentina STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 101 Argentina STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 102 Argentina STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 103 MEA STD diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 104 MEA STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 105 MEA STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 106 MEA STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 107 MEA STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 108 South Africa STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 109 South Africa STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 110 South Africa STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 111 South Africa STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 112 Saudi Arabia STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 116 UAE STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 117 UAE STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 118 UAE STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 119 UAE STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 120 Kuwait STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 121 Kuwait STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 122 Kuwait STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 123 Kuwait STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 STD Diagnostics Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market outlook (2023)
  • Fig. 10 Penetration and growth prospect mapping
  • Fig. 11 User perspective analysis
  • Fig. 12 STD Diagnostics Market driver impact
  • Fig. 13 Prevalence of STIs by WHO regions (in 2023)
  • Fig. 14 STD Diagnostics Market restraint impact
  • Fig. 15 SWOT Analysis, By Factor (Political & Legal, Economic, and Technological)
  • Fig. 16 Porter's Five Forces Analysis
  • Fig. 17 STD diagnostics product outlook: Key takeaways
  • Fig. 18 STD Diagnostics Market: Product movement analysis
  • Fig. 19 Instruments and Services market, 2018 - 2030 (USD Million)
  • Fig. 20 Consumables market, 2018 - 2030 (USD Million)
  • Fig. 21 Software market, 2018 - 2030 (USD Million)
  • Fig. 22 STD diagnostics application outlook: Key takeaways
  • Fig. 23 STD Diagnostics Market: Application movement analysis
  • Fig. 24 CT/NG testing market, 2018 - 2030 (USD Million)
  • Fig. 25 Prevalence (%) of syphilis by WHO regions
  • Fig. 26 Syphilis testing market, 2018 - 2030 (USD Million)
  • Fig. 27 Syphilis PCR testing market, 2018 - 2030 (USD Million)
  • Fig. 28 Syphilis non-PCR testing market, 2018 - 2030 (USD Million)
  • Fig. 29 HSV testing market, 2018 - 2030 (USD Million)
  • Fig. 30 Herpes Simplex Virus PCR testing market, 2018 - 2030 (USD Million)
  • Fig. 31 Herpes Simplex Virus non-PCR testing market, 2018 - 2030 (USD Million)
  • Fig. 32 HPV testing market, 2018 - 2030 (USD Million)
  • Fig. 33 Prevalence (%) of HIV by WHO regions
  • Fig. 34 HIV testing market, 2018 - 2030 (USD Million)
  • Fig. 35 Ureaplasma & mycoplasma testing market, 2018 - 2030 (USD Million)
  • Fig. 36 Trichomonas testing market, 2018 - 2030 (USD Million)
  • Fig. 37 VZV testing market, 2018 - 2030 (USD Million)
  • Fig. 38 VZV PCR testing market, 2018 - 2030 (USD Million)
  • Fig. 39 VZV non-PCR testing market, 2018 - 2030 (USD Million)
  • Fig. 40 Other testing market, 2018 - 2030 (USD Million)
  • Fig. 41 STD diagnostics technology outlook: Key takeaways
  • Fig. 42 STD Diagnostics Market: Technology movement analysis
  • Fig. 43 Molecular Diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 44 Immunoassay market, 2018 - 2030 (USD Million)
  • Fig. 45 Others market, 2018 - 2030 (USD Million)
  • Fig. 46 STD diagnostics location of testing outlook: Key takeaways
  • Fig. 47 STD Diagnostics Market: Location of testing movement analysis
  • Fig. 48 Laboratory testing market, 2018 - 2030 (USD Million)
  • Fig. 49 Commercial/private labs market, 2018 - 2030 (USD Million)
  • Fig. 50 Public health labs market, 2018 - 2030 (USD Million)
  • Fig. 51 Point of care testing market, 2018 - 2030 (USD Million)
  • Fig. 52 Regional outlook, 2023 & 2030
  • Fig. 53 Regional marketplace: Key takeaways
  • Fig. 54 North America SWOT
  • Fig. 55 North America STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 56 U.S. Country Dynamics
  • Fig. 57 U.S. Target Disease Prevalence
  • Fig. 58 U.S. STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 59 Canada Country Dynamics
  • Fig. 60 Canada Target Disease Prevalence
  • Fig. 61 Canada STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 61 Mexico Target Disease Prevalence
  • Fig. 62 Mexico STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 62 Europe SWOT
  • Fig. 63 Europe STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 64 UK Country Dynamics
  • Fig. 65 UK Target Disease Prevalence
  • Fig. 66 UK STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 67 Germany Country Dynamics
  • Fig. 68 Germany Target Disease Prevalence
  • Fig. 69 Germany STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 70 France Country Dynamics
  • Fig. 71 France Target Disease Prevalence
  • Fig. 72 France STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 73 Spain Country Dynamics
  • Fig. 74 Spain Target Disease Prevalence
  • Fig. 75 Spain STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 76 Italy Country Dynamics
  • Fig. 77 Italy Target Disease Prevalence
  • Fig. 78 Italy STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 79 Denmark Country Dynamics
  • Fig. 80 Denmark Target Disease Prevalence
  • Fig. 81 Denmark STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 82 Sweden Country Dynamics
  • Fig. 83 Sweden Target Disease Prevalence
  • Fig. 84 Sweden STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 85 Denmark Country Dynamics
  • Fig. 86 Denmark Target Disease Prevalence
  • Fig. 87 Denmark STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 88 Asia Pacific SWOT
  • Fig. 89 Asia Pacific STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 90 Japan Country Dynamics
  • Fig. 91 Japan Target Disease Prevalence
  • Fig. 92 Japan STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 93 China Country Dynamics
  • Fig. 94 China Target Disease Prevalence
  • Fig. 95 China STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 96 India Country Dynamics
  • Fig. 97 India Target Disease Prevalence
  • Fig. 98 India STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 99 Australia Country Dynamics
  • Fig. 100 Australia Target Disease Prevalence
  • Fig. 101 Australia STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 102 South Korea Country Dynamics
  • Fig. 103 South Korea Target Disease Prevalence
  • Fig. 104 South Korea STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 105 Thailand Country Dynamics
  • Fig. 106 Thailand Target Disease Prevalence
  • Fig. 107 Thailand STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 108 Latin America SWOT
  • Fig. 109 Latin America STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 110 Brazil Country Dynamics
  • Fig. 111 Brazil Target Disease Prevalence
  • Fig. 112 Brazil STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 113 Mexico Country Dynamics
  • Fig. 116 Argentina Country Dynamics
  • Fig. 117 Argentina Target Disease Prevalence
  • Fig. 118 Argentina STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 119 Middle East & Africa SWOT
  • Fig. 120 Middle East & Africa STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 121 South Africa Country Dynamics
  • Fig. 122 South Africa Target Disease Prevalence
  • Fig. 123 South Africa STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 124 Saudi Arabia Country Dynamics
  • Fig. 125 Saudi Arabia Target Disease Prevalence
  • Fig. 126 Saudi Arabia STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 127 UAE Country Dynamics
  • Fig. 128 UAE Target Disease Prevalence
  • Fig. 129 UAE STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 130 Kuwait Country Dynamics
  • Fig. 131 Kuwait Target Disease Prevalence
  • Fig. 132 Kuwait STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 133 Heat map analysis
  • Fig. 134 Company market share analysis (2024)
  • Fig. 135 Company market position analysis (2024)
  • Fig. 136 Company market position analysis (2024)
  • Fig. 137 Market differentiators
  • Fig. 138 Regional Network Map